Explore more publications!

Press Releases

Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Whisper Opens 16th Worldwide Office in Reykjavík With Your Friend in Reykjavik
Towards a Shared Arctic Vision: Japan and the Nordic States in an Interconnected World

Towards a Shared Arctic Vision: Japan and the Nordic States in an Interconnected World

2026 Global PassportRanking Top 10: Why Traditional Visa-Free Leaders Are Falling Behind
Oculis to Participate in Upcoming Investor Conferences
Alvotech Files Annual Report with the SEC
Empress Shōken Fund announces 2026 funding decisions

Empress Shōken Fund announces 2026 funding decisions

Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
2025 full year financial results
From design to daily operations: Flashnet's customer-centric support services for more reliable smart street lighting
Alvotech Q4 2025 and Full Year 2025 Financial Results
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
The Arctic This Week Take Five: Week of 23 March, 2026

The Arctic This Week Take Five: Week of 23 March, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Tests of fridges show positive results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions